924309-93-3 Usage
General Description
2-Acetamidonon-8-enoic acid, also known as AMNE, is a chemical compound that belongs to the family of non-steroidal anti-inflammatory drugs (NSAIDs). It has been studied for its potential therapeutic effects in the treatment of various inflammatory and pain conditions. AMNE has been found to inhibit the activity of the enzyme cyclooxygenase (COX), which is responsible for the production of pro-inflammatory prostaglandins. This inhibition of COX activity leads to a reduction in inflammation and pain. Additionally, AMNE has been shown to have antioxidant and neuroprotective properties, making it a potential candidate for the treatment of neurodegenerative diseases. Further research is needed to fully understand the potential therapeutic applications of 2-Acetamidonon-8-enoic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 924309-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,4,3,0 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 924309-93:
(8*9)+(7*2)+(6*4)+(5*3)+(4*0)+(3*9)+(2*9)+(1*3)=173
173 % 10 = 3
So 924309-93-3 is a valid CAS Registry Number.
924309-93-3Relevant articles and documents
COMPOUNDS AS HEPATITIS C INHIBITORS AND USES THEREOF IN MEDICINE
-
, (2016/09/22)
Provided herein are compounds as hepatitis C inhibitors and uses thereof in medicine. Specifically, provided herein is a compound of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or hepatitis C diseases. Also provided herein are a pharmaceutically acceptable composition containing such compound and a method of treating HCV infection or hepatitis C diseases comprising administering the compound or pharmaceutical composition thereof disclosed herein.
